Sienna Biopharmaceuticals (SNNAQ) Stock Statistics & Valuation Metrics

Sienna Biopharmaceuticals has a market cap or net worth of $31.00. The enterprise value is -$18.40M.

Sienna Biopharmaceuticals has 30,908,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sienna Biopharmaceuticals’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -92.02%.

The current PE Ratio of Sienna Biopharmaceuticals is ―. Sienna Biopharmaceuticals’s PEG ratio is 0.00.

In the last 12 months, Sienna Biopharmaceuticals had revenue of 0.00 and earned -73.31M in profits. Earnings per share was -3.59.

In the last 12 months, operating cash flow was -54.63M and capital expenditures -10.00K, giving a free cash flow of -54.64M billion.

Sienna Biopharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Sienna Biopharmaceuticals upcoming earnings date is ―, ―.

Sienna Biopharmaceuticals as a current ratio of ―, with Debt / Equity ratio of 18.90%

In the past 12 months, Sienna Biopharmaceuticals has paid -157.00K in taxes.

Sienna Biopharmaceuticals EV to EBITDA ratio is -0.38, with an EV/FCF ratio of -0.47.

Sienna Biopharmaceuticals has $11.33M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.33M billion.

Gross margin is 0.00%, with operating margin of ―, and net profit margin of ―.

The average price target for Sienna Biopharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―